A Study of GC201 TIL in Advanced Gynecologic Tumors (10hospital)

Clinical trial NCT05098171 · RECRUITING

Trial details

NCT number: NCT05098171
Sponsor: Shanghai Juncell Therapeutics
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Advanced Gynecologic Tumors Signal Switch Receptor Modified TIL Treatment Side Effects Effects of Immunotherapy

Start date: 2021-09-26
Primary completion: 2026-09-25
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.